Abstract:Background RNF213 is a major susceptibility gene for moyamoya disease (MMD), characterized by chronic progressive steno‐occlusion of the intracranial arteries. However, coincidental extracranial arteriopathy is sporadically described in a few cases and in children with MMD. Methods and Results This study prospectively enrolled 63 young adults (aged 20–49 years) without a known history of systemic vascular diseases who were confirmed to have definite (bilateral, n=54) or probable (unilateral, n=9) MMD, as per typical angiographic findings. Coronary and aorta computed tomography angiography was performed to characterize extracranial arteriopathy and investigate its correlation with clinical characteristics and MMD status, including the RNF213 p.Arg4810Lys variation (c.14429G>A, rs112735431). Altogether, 11 of 63 patients (17%) had significant (>50%) stenosis in the coronary (n=6), superior mesenteric (n=2), celiac (n=2), renal (n=1), and/or internal iliac artery (n=1). One patient showed both mesenteric and iliac artery stenosis. Patients with extracranial arteriopathy were more likely to have diabetes mellitus and posterior cerebral artery involvement. Moreover, a higher prevalence of extracranial arteriopathy was observed in the presence of the RNF213 p.Arg4810Lys variant (67% in homozygotes). After controlling for diabetes mellitus and posterior cerebral artery involvement, the p.Arg4810Lys variant was independently associated with extracranial arteriopathy (additive model; P =0.035; adjusted odds ratio, 4.57; 95% CI, 1.11–27.20). Conclusions Young adults with MMD may have concomitant extracranial arteriopathy in various locations. Patients with RNF213 variants, especially the p.Arg4810Lys homozygous variant, should be screened for systemic arteriopathy. Nonstandard Abbreviations and Acronyms CACTA coronary and aorta computed tomography angiography DSA digital subtraction angiography ECG electrocardiography ICA internal carotid artery MMD moyamoya disease PCA posterior cerebral artery PPAS peripheral pulmonary artery stenosis Clinical Perspective What Is New? Prospective screening of extracranial systemic arteriopathy in young adults with moyamoya disease revealed that 11 of 63 patients (17%) had significant (>50%) stenosis in the coronary, superior mesenteric, celiac, renal, and/or internal iliac artery. A higher prevalence of extracranial arteriopathy was observed in the presence of the RNF213 p.Arg4810Lys variant (8% in wild‐types, 14% in heterozygotes, and 67% in homozygotes). What Are the Clinical Implications? Patients with RNF213 variants, especially the p.Arg4810Lys homozygous variant, should be screened for systemic arteriopathy. Moyamoya disease (MMD) is characterized by chronic progressive steno‐occlusion at the terminal portion of the internal carotid artery (ICA), the proximal portion of the anterior cerebral artery, and/or the middle cerebral artery, with concomitant abnormal collateral networks. 1 The pathogenesis of MMD remains unclear. However, RNF213 has been identified as a major susceptibility gene for MMD. 2 , 3 Among East Asian individuals with MMD, 95% to 100% of familial cases, and 73% to 87% of nonfamilial cases had the founder variant of RNF213 , p.Arg4810Lys (c.14429G>A, rs112735431). 2 , 3 , 4 Homozygosity for the RNF213 p.Arg4810Lys variant, detected in 2% to 7% of cases in previous studies, 2 , 3 , <a class="tab-link" href="#jah35548-bi -Abstract Truncated-

Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo

Identification of Rnf213 As A Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development

RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway

RNF213 in moyamoya disease: Genotype–phenotype association and the underlying mechanism

RNF213 polymorphism and Moyamoya disease: A systematic review and meta-analysis.

Different phenotypes of moyamoya disease in a Chinese familial case involving heterozygous c.14429G>a variant in RNF213

Rnf-213 Knockout Induces Pericyte Reduction and Blood-Brain Barrier Impairment in Mouse

Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population.

RNF213 Loss-of-Function Promotes Angiogenesis of Cerebral Microvascular Endothelial Cells in a Cellular State Dependent Manner

RNF213 Mutation Associated with the Progression from Middle Cerebral Artery Steno-Occlusive Disease to Moyamoya Disease

Association of rare variants in RNF213 with severe progression of intracranial artery stenosis in quasi-moyamoya disease

Peripheral blood GATA2 expression impacts RNF213 mutation penetrance and clinical severity in moyamoya disease

Peripheral blood expression impacts mutation penetrance and clinical severity in moyamoya disease

Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians

The Susceptibility Pathogenesis of Moyamoya Disease

An analysis of the demographic history of the risk allele R4810K in RNF213 of moyamoya disease

Prospective Screening of Extracranial Systemic Arteriopathy in Young Adults with Moyamoya Disease.

Association of Genetic Variants with Postoperative Donor Artery Development in Moyamoya Disease: RNF213 and Other Moyamoya Angiopathy-Related Gene Analysis

Molecular structure and function of mysterin/RNF213

RNF213 p.R4810K variant in moyamoya disease in adults and children from a Malaysian tertiary center

Mutation of Rnf213a by Talen Causes Abnormal Angiogenesis and Circulation Defects in Zebrafish